文献速递主动脉疾病

全球与靶向代谢组学识别急性主动脉夹层血清生物标志物

Identification of Serum Biomarker in Acute Aortic Dissection by Global and Targeted Metabolomics.
PubMed 文献 · Ann Vasc Surg · 2020-06-26

结果显示磷脂酰胆碱代谢通路显著改变,TMAO水平升高而肉碱、胆碱和甜菜碱降低,TMAO与疾病严重程度及炎症指标相关,可能作为AAD辅助诊断和评估的生物标志物。

要点

  • AAD患者血清磷脂酰胆碱代谢通路显著改变,TMAO水平明显升高。
  • TMAO与CRP、IL-6、D-二聚体及最大主动脉直径正相关。
  • TMAO可能作为AAD辅助诊断和病情评估的潜在生物标志物。

核心结论

  • AAD患者代谢物水平呈现以磷脂酰胆碱代谢通路为主的一致改变,TMAO可能作为辅助诊断和评估AAD的生物标志物。

主要发现

  • 非靶向代谢组学显示AAD患者脂质和极性代谢物显著变化,靶向代谢组学进一步观察到磷脂酰胆碱代谢通路改变。
  • AAD患者TMAO水平较对照明显升高(P < 0.005),肉碱(P < 0.005)、胆碱和甜菜碱(P < 0.05)水平降低。
  • TMAO水平与AAD疾病严重程度相关,并与C反应蛋白(r = 0.537,P = 0.018)、IL-6(r = 0.546,P = 0.016)、D-二聚体(r = 0.694,P = 0.001)及入院时最大主动脉直径(r = 0.748,P = 0.002)呈正相关。

临床怎么用

  • TMAO可能作为AAD辅助诊断和病情评估的血清标志物,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute aortic dissection (AAD) is the most devastating aortic pathology, and the incidence is increasing worldwide. However, the occurrence and development of AAD are unpredictable. A thorough understanding of the serum metabolic landscape through metabolomic analysis may help identify new biomarkers for AAD and offers new insights into its prevention and evaluation. METHODS: Nineteen patients with Stanford type A aortic dissection and 20 healthy individuals were enrolled in this study. We use global and targeted mass spectrometry-based metabolomics to investigate the serum metabolomics profiles, and the data were analyzed by principal component analysis and orthogonal partial least squares discriminant analysis. RESULTS: Initial untargeted metabolomics analysis revealed significant changes of lipids and polar metabolites in patients with AAD. Alterations of the phosphatidylcholine metabolic pathway were further observed by targeted metabolomics. Trimethylamine N-oxide (TMAO) levels were obviously increased in patients with AAD compared with controls (P < 0.005), whereas the levels of carnitine (P < 0.005), choline, and betaine (P < 0.05) were decreased. Furthermore, TMAO levels were associated with disease severity in AAD and correlated positively with C-reactive protein levels (r = 0.537, P = 0.018), IL-6 levels (r = 0.546, P = 0.016), D-dimer levels (r = 0.694, P = 0.001), and maximum aortic diameter on admission (r = 0.748, P = 0.002). CONCLUSIONS: Patients with AAD showed a predominant and consistent change of metabolites levels, especially the compounds in the phosphatidylcholine metabolic pathway. TMAO could potentially serve as a biomarker for the auxiliary diagnosis and evaluation of AAD.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zeng Q, Rong Y, Li D, et al. Identification of Serum Biomarker in Acute Aortic Dissection by Global and Targeted Metabolomics. Ann Vasc Surg. 2020. PMID: 32599111. doi:10.1016/j.avsg.2020.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。